Gee‐Chen Chang

10.0k citations
124 papers · 3.2k indexed · 2 hit papers · h-index 30

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 32
    • Colorectal Cancer Treatments and Studies 20
    • Cancer Immunotherapy and Biomarkers 11
    • Pancreatic and Hepatic Oncology Research 8
    • Lung Cancer Treatments and Mutations 89
    • Lung Cancer Diagnosis and Treatment 23
    • Gastric Cancer Management and Outcomes 9

Gee‐Chen Chang

117 papers receiving 3.1k citations

Hit Papers

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study 2016 · 502 citations
5022012202620162021100200300400500

Peers

Gee‐Chen Chang
Comparison fields: 5 of 120
  • Oncology 1.7k
  • Pulmonary and Respiratory Medicine 1.9k
  • Cancer Research 686
  • Molecular Biology 1.1k
  • Pathology and Forensic Medicine 241
Replace Teresa A. Goldin with:
Teresa A. Goldin United States
Alexander Barsouk United States
Carlos Gil Ferreira Brazil
Raghunadharao Digumarti India
Maja J.A. de Jonge Netherlands
Anne S. Tsao United States
Kalyan Saginala United States
Winston Tan United States
Maurizio Brausi Italy
D. Vucicevic United States
Gee‐Chen Chang relative to Teresa A. Goldin United States Teresa A. Goldin's profile →
Citations per field
00.5×10×15×18.9×
Teresa A. Goldin · 1×
Citations per year

Countries citing papers authored by Gee‐Chen Chang

Since Specialization
Citations

This map shows the geographic impact of Gee‐Chen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gee‐Chen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gee‐Chen Chang more than expected).

Fields of papers citing papers by Gee‐Chen Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gee‐Chen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gee‐Chen Chang. The network helps show where Gee‐Chen Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Gee‐Chen Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gee‐Chen Chang Line = papers co-authored together Gee‐Chen Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20240
3 20243
4 20241
5 20241
6 20245
7 20240
8 20232
9 20233
10 20228
11 20226
12 202210
13 20224
14 20221
15 20212
16 202110
17 202114
18 201820
19
Pulmonary Cement Embolism: A Case Report and Review of the Literature
20160
20
Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
Hit paper breakdown →
2012429

About Gee‐Chen Chang

Gee‐Chen Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Internal Medicine, having authored 124 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (89 papers), Lung Cancer Research Studies (32 papers), Lung Cancer Diagnosis and Treatment (23 papers), Colorectal Cancer Treatments and Studies (20 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Immunotherapy and Biomarkers (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.9k citations), Cancer Research (686 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (241 citations). Gee‐Chen Chang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Tsung‐Ying Yang, Sung‐Liang Yu, Kun‐Chieh Chen, Kang‐Yi Su, Pan‐Chyr Yang, Kuo-Hsuan Hsu, Jeremy J.W. Chen, Jeng‐Sen Tseng, Jin‐Yuan Shih and James Chih‐Hsin Yang. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026